Cryptosporidiosis is an intestinal parasitic infection that is emerging as a common cause of diarrhea worldwide. The potential for use of Cryptosporidium in bioterrorism is illustrated by the 1993 epidemic that occurred when the Milwaukee water supply became contaminated with the organism and over 400,000 people became ill with diarrhea within a period of a few weeks. Associated with that outbreak were large numbers of hospitalizations and deaths. Based on this potential to cause large-scale epidemics, Cryptosporidium has been classified as a Class B agent for biodefense. According to the World Health Organization, diarrheal diseases are the second most common cause of morbidity and mortality worldwide among children in developing countries and also an important cause of morbidity and mortality in adults, Parasites are more common agents of persistent and chronic diarrhea, which are increasingly recognized as major causes of chronic morbidity. Among the parasites Cryptosporidium, Giardia intestinalis, and Entamoeba histolytica are the most commonly associated with diarrhea. All of these organisms can present with a similar clinical picture, typically with watery diarrhea, yet they differ in terms of optimal diagnostic methods and, more importantly, treatment. The long-range goal for the project is to develop a simple, inexpensive test that can detect all the major diarrhea-causing protozoan parasites that can be performed at the point-of-care, even in developing countries.
The specific aims of this project are:
Specific aim 1 : To optimize an inexpensive, sensitive and specific diagnostic test that can be used for point-of-care diagnosis of Cryptosporidiosis.
Specific aim 2 : To develop detection methods for Giardia, E. histolytica, Cyc/ospora, and /sospora.
Specific aim 3 : To assess the sensitivity and specificity of these assays using stools samples obtained in prospective studies of diarrheal disease. To accomplish these goals, we have assembled an interdisciplinary team with proven expertise in point-of-care detection of infectious disease. Dr White's laboratory at UTMB brings expertise in intestinal parasites, clinical infectious diseases and parasite molecular biology and has ongoing collaborations with field studies of diarrheal disease. Dr. Richards-Kortum's Laboratory, at the Department of Bioengineering at Rice University, has focused on applying microfabrication and nanotechnologies to global health problems and has experience in both micro-optical sensors and the use of targeted nanoparticles for molecular diagnostics. The long-range goal for the project will be to incorporate similar techniques to develop a simple, inexpensive test that can detect all the major diarrhea-causing protozoan parasites that can be performed at the point-ofcare, even in developing countries.
|Paterson, Andrew S; Raja, Balakrishnan; Garvey, Gavin et al. (2014) Persistent luminescence strontium aluminate nanoparticles as reporters in lateral flow assays. Anal Chem 86:9481-8|
|Santiago, Felix W; Covaleda, Lina M; Sanchez-Aparicio, Maria T et al. (2014) Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses. J Virol 88:4572-85|
|Pflughoeft, Kathryn J; Swick, Michelle C; Engler, David A et al. (2014) Modulation of the Bacillus anthracis secretome by the immune inhibitor A1 protease. J Bacteriol 196:424-35|
|Lavinder, Jason J; Wine, Yariv; Giesecke, Claudia et al. (2014) Identification and characterization of the constituent human serum antibodies elicited by vaccination. Proc Natl Acad Sci U S A 111:2259-64|
|Valbuena, Gustavo; Halliday, Hailey; Borisevich, Viktoriya et al. (2014) A human lung xenograft mouse model of Nipah virus infection. PLoS Pathog 10:e1004063|
|Nieves, Wildaliz; Petersen, Hailey; Judy, Barbara M et al. (2014) A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin Vaccine Immunol 21:747-54|
|Gardner, Christina L; Hritz, Jozef; Sun, Chengqun et al. (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis 8:e2719|
|Litvinov, Julia; Hagström, Anna E V; Lopez, Yubitza et al. (2014) Ultrasensitive immuno-detection using viral nanoparticles with modular assembly using genetically-directed biotinylation. Biotechnol Lett 36:1863-8|
|Caro-Gomez, Erika; Gazi, Michal; Goez, Yenny et al. (2014) Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approach. Vaccine 32:4968-76|
|Georgiou, George; Ippolito, Gregory C; Beausang, John et al. (2014) The promise and challenge of high-throughput sequencing of the antibody repertoire. Nat Biotechnol 32:158-68|
Showing the most recent 10 out of 303 publications